@article {Indrayan2020.10.24.20218693, author = {Abhaya Indrayan and Aman Mishra and Mona Pathak}, title = {Preliminary Estimates of Years of Life Lost (YLL) Due to COVID-19 in India}, elocation-id = {2020.10.24.20218693}, year = {2020}, doi = {10.1101/2020.10.24.20218693}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Objectives More than 7 million cases of COVID have been detected in India by the middle of October 2020 and more than 100 thousand deaths have occurred. In this communication, we present an estimate of the years of life lost (YLL) due to COVID-19 so far and the projection for the full year so that the health damage by this new disease can be compared with some other ailments.Design Records based studyMethod The YLL by one premature death is the expectation of life at that age. To calculate YLL, the age-wise distribution of COVID cases and deaths was obtained from the official sources of the government of India. Similar calculations were done for the general population from all causes for comparison.Results A total of more than 2 million years of life have already lost due to COVID-19 and the pattern indicates that we may end up with nearly 4 million YLL due to this disease in India. This is nearly 20 years lost per COVID death, 303 years lost per 1000 cases of COVID, and about 3 years lost per 1000 population in a full year. The age-group 50{\textendash}59 years has been particularly affected. Other important findings are summarized as key messages.Conclusion The years of life lost so far and anticipated in full-year are enormous but may still be lower compared with some other causes such as road injuries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The paper is based on the data in the public domain. Thus, no approval or exemption from any oversight body is needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are taken from the public domain}, URL = {https://www.medrxiv.org/content/early/2020/11/30/2020.10.24.20218693}, eprint = {https://www.medrxiv.org/content/early/2020/11/30/2020.10.24.20218693.full.pdf}, journal = {medRxiv} }